HYPERBILIRUBINEMIA, ROTOR TYPE, DIGENIC
|
phenotype |
|
Finding
|
2
|
|
0.300 |
limited |
1.000 |
1 |
|
2012 |
2012 |
Rotor Syndrome
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
3
|
2
|
0.730 |
limited |
1.000 |
4 |
2
|
2007 |
2015 |
Mucosal erosion
|
phenotype |
|
Acquired Abnormality
|
4
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
ESTRONE MEASUREMENT
|
phenotype |
|
Laboratory Procedure
|
5
|
7
|
0.100 |
None |
1.000 |
1 |
1
|
2017 |
2017 |
Hepatic impairment
|
phenotype |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Sex hormone binding globulin measurement
|
phenotype |
|
Laboratory Procedure
|
11
|
21
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Abnormality of the gastric mucosa
|
disease |
|
Anatomical Abnormality
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
ABO incompatibility
|
disease |
Immune System Diseases; Hemic and Lymphatic Diseases
|
Disease or Syndrome
|
14
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Bleeding ulcer
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
16
|
1
|
0.020 |
None |
1.000 |
2 |
|
2014 |
2015 |
Estradiol measurement
|
phenotype |
|
Laboratory Procedure
|
21
|
75
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Estradiol level result
|
phenotype |
|
Laboratory or Test Result
|
21
|
75
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Unconjugated hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
23
|
4
|
0.030 |
None |
1.000 |
3 |
|
2005 |
2014 |
Thyroxine measurement
|
phenotype |
|
Laboratory Procedure
|
24
|
42
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
progesterone receptor-negative breast cancer
|
disease |
|
Neoplastic Process
|
24
|
11
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Muscle Cramp
|
phenotype |
Pathological Conditions, Signs and Symptoms; Musculoskeletal Diseases; Nervous System Diseases
|
Sign or Symptom
|
26
|
8
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
progesterone receptor-positive breast cancer
|
disease |
|
Neoplastic Process
|
28
|
17
|
0.010 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Progressive intrahepatic cholestasis (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Digestive System Diseases; Nutritional and Metabolic Diseases; Skin and Connective Tissue Diseases
|
Disease or Syndrome
|
31
|
10
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Bilirubin level result
|
phenotype |
|
Laboratory or Test Result
|
32
|
478
|
0.100 |
None |
1.000 |
2 |
12
|
2009 |
2011 |
Conjugated hyperbilirubinemia
|
disease |
Pathological Conditions, Signs and Symptoms
|
Disease or Syndrome
|
32
|
1
|
0.110 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hyperbilirubinemia, Neonatal
|
disease |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
33
|
15
|
0.060 |
None |
1.000 |
6 |
3
|
2009 |
2019 |
Neonatal Jaundice
|
phenotype |
Pathological Conditions, Signs and Symptoms; Congenital, Hereditary, and Neonatal Diseases and Abnormalities
|
Disease or Syndrome
|
33
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Chagas Cardiomyopathy
|
disease |
Infections; Cardiovascular Diseases
|
Disease or Syndrome
|
37
|
8
|
0.100 |
None |
1.000 |
1 |
1
|
2013 |
2013 |
Focal nodular hyperplasia of liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
39
|
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Familial hypercholesterolemia - heterozygous
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
42
|
34
|
0.010 |
None |
1.000 |
1 |
1
|
2006 |
2006 |
Torsades de Pointes
|
disease |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
51
|
14
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |